NLI vs Valhi
NL and VHI side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How NL and VHI compare
Valhi is the larger company, worth 1.4 times as much as NLI ($477M against $348M).
NLI grew revenue faster over the last twelve months (6.0% versus 3.4% for Valhi).
Valhi keeps more of each dollar of sales as profit, with a net margin of −2.4% compared with −15.8% at NLI.
Both pay dividends: NLI yields 5.5% and Valhi 1.9%.
NLI scores higher on the StockData Score (13 against 7 for Valhi), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | NL | VHI |
|---|---|---|
| Size and price | ||
| Market cap | $348M | $477M |
| Share price | $7.11 | $16.85 |
| Change, 1 year | 28.3% | 30.2% |
| Change, 5 years | 14.5% | −36.9% |
| Beta (5Y) | 0.53 | 0.06 |
| Employees | 549 | 549 |
| StockData Score | ||
| Total score | 13 (better) | 7 |
| Valuation score | 2 | 3 (better) |
| Growth score | 2 (better) | 0 |
| Performance score | 0 | 0 |
| Health score | 6 (better) | 2 |
| Dividend score | 3 (better) | 2 |
| Valuation | ||
| P/S | 2.1× | 0.2× (better) |
| P/B | 1.0× | 0.5× (better) |
| EV/EBITDA | 14.0× | 8.2× (better) |
| P/FCF | 42.9× | 7.6× (better) |
| FCF yield | 2.3% | 13.1% (better) |
| Fair value | $7.67 | $43.97 |
| Margin of safety | 7.3% | 61.7% (better) |
| Growth | ||
| Revenue growth (TTM) | 6.0% (better) | 3.4% |
| Revenue growth, 5Y average | 6.7% (better) | 2.3% |
| Net income growth (TTM) | −148% (better) | −152% |
| EPS growth (TTM) | −147% | – |
| Profitability | ||
| Gross margin | 32.1% (better) | 14.7% |
| Operating margin | 9.2% (better) | 3.6% |
| Net margin | −15.8% | −2.4% (better) |
| FCF margin | 5.0% (better) | 2.9% |
| Return on equity | −6.7% | −4.8% (better) |
| Return on invested capital | 4.4% (better) | 4.2% |
| Financial health | ||
| Debt / equity | 0.00 | 0.56 (better) |
| Net debt / EBITDA | – | 2.56 |
| Interest coverage | 122× (better) | 1.3× |
| Current ratio | 9.02 (better) | 3.37 |
| Altman Z-score | 3.92 (better) | 1.87 |
| Piotroski F-score | 4 (better) | 3 |
| Dividends and buybacks | ||
| Dividend yield | 5.5% (better) | 1.9% |
| Years of dividend growth | 0 | 0 |
| Dividend growth, 5Y average | 28.9% (better) | −7.8% |
| Shareholder yield | 5.5% (better) | 1.9% |
| Ownership | ||
| Held by institutions | 11.3% | 4.2% |
| Held by insiders | 0.41% | 0.26% |
| Short interest, % of float | 0.19% | 0.21% |
Go deeper
- NL stock overview
- NL income statement
- NL valuation and score
- VHI stock overview
- VHI income statement
- VHI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.